Trial Profile
An Exploratory Study to Evaluate the Effect of Abatacept (BMS-188667) on the Antibody Response Following Tetanus Toxoid and 23-Valent Pneumococcal Vaccinations in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Pneumococcal vaccine; Tetanus vaccine
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Bristol-Myers Squibb
- 11 Apr 2011 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 12 Sep 2008 New trial record.